Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02706093 · ClinicalTrials.gov registry record · NA
Metabolic Adaptations in Response to High Intensity Interval Training in Obese Adults
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 129
- Enrollment target
NCT02706093: Completed NA study, sponsored by University of Michigan.
NCT02706093 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 129 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02706093, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 129 participants
- Enrollment target
Study Summary
The overall objectives are to: 1. Assess mechanisms underlying HIIT-induced improvements in insulin resistance at the whole-body, tissue, and cellular levels. 2. Systematically compare different HIIT regimens to help identify effective "doses" of HIIT that may be optimal for improving metabolic health in obese adults. 3. Assess the ability/willingness of obese subjects to adhere to a long-term HIIT program. Findings from these studies will greatly expand knowledge about the effects of HIIT on metabolic health, and will provide valuable information for development of programs aimed at maximizing key metabolic benefits of exercise.
Primary Outcome
A hyperinsulinemic-euglycemic clamp was used to assess peripheral insulin sensitivity. Briefly, a primed, continuous infusion of insulin (40 mU/m\^2/min) was administered; blood glucose was assessed every 5 minutes and 20% dextrose (D20 enriched with \[6-6 d2\]glucose) was infused at a variable rate to accommodate changes in blood glucose in order to maintain blood glucose at the participants' overnight fasted levels. About 2 hours after beginning the insulin infusion, when blood glucose concent
Interventions
- OTHER Moderate intensity continuous training
- OTHER High Intensity Interval Training #1
- OTHER High Intensity Interval Training #2
- OTHER High Intensity Interval Training #3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2016-05-03 |
| Est. Completion | 2022-05-04 |
| Phase | NA |
What the finished NCT02706093 record still lists
NCT02706093 is an interventional study that assigns participants to a tested intervention. The registered 129 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 4 interventions - of which Moderate intensity continuous training is the first listed.
NCT02706093 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02706093 about?
NCT02706093 is a clinical study titled "Metabolic Adaptations in Response to High Intensity Interval Training in Obese Adults". The overall objectives are to: 1. Assess mechanisms underlying HIIT-induced improvements in insulin resistance at the whole-body, tissue, and cellular levels. 2. Systematically compare different HIIT regimens to help identify effective "doses" of HIIT that may be optimal for improving metabolic hea...
What is the current status of trial NCT02706093?
This trial is currently completed. It is a NA study. The enrollment target is 129 participants. The study started on 2016-05-03. Estimated completion is 2022-05-04.
What interventions are being tested in trial NCT02706093?
The interventions under investigation include: Moderate intensity continuous training (OTHER), High Intensity Interval Training #1 (OTHER), High Intensity Interval Training #2 (OTHER), High Intensity Interval Training #3 (OTHER).
Who is sponsoring clinical trial NCT02706093?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02706093's enrollment target sits among peer trials
129 744th of 2000 higher than 1,257 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03619850 · 129 participants · Phase 3
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
- NCT05704361 · 129 participants · Phase 1
A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis
- NCT05919849 · 129 participants · Phase 1
Supporting Parents in Affirming Their Children's Experiences of Stigma
- NCT06313749 · 129 participants · NA
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI